Aspiriant LLC Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Aspiriant LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,482 shares of the healthcare conglomerate’s stock after acquiring an additional 174 shares during the period. Aspiriant LLC’s holdings in UnitedHealth Group were worth $2,621,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in UNH. Harbor Investment Advisory LLC raised its position in UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after purchasing an additional 1,129 shares during the period. Austin Private Wealth LLC lifted its stake in shares of UnitedHealth Group by 9.8% in the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after acquiring an additional 111 shares during the last quarter. Capital Insight Partners LLC grew its position in UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after acquiring an additional 332 shares during the last quarter. Global Assets Advisory LLC bought a new stake in UnitedHealth Group in the first quarter valued at approximately $282,469,000. Finally, Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $2,905,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $569.61 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The company has a market capitalization of $525.99 billion, a price-to-earnings ratio of 37.77, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company’s 50-day moving average is $584.42 and its 200 day moving average is $533.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.

Analyst Ratings Changes

A number of brokerages have issued reports on UNH. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday. KeyCorp assumed coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Barclays raised their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.